What agent can treat ACE inhibitor–induced angioedema due to bradykinin?

What agent can treat ACE inhibitor–induced angioedema due to bradykinin?

• A. Epinephrine
• B. Cromolyn sodium
• C. Hydrocortisone
• D. Icatibant

Answer: (D)

ACE inhibitor–induced angioedema is driven by excess bradykinin because these drugs prevent its breakdown, leading to edema that is not primarily driven by histamine. Treatments that block histamine or rely on allergic pathways often don’t work well in this scenario. Icatibant is a selective bradykinin B2 receptor antagonist, so it directly blocks the effects of bradykinin on blood vessels, reducing vasodilation and vascular permeability and shortening the swelling. That direct mechanism makes it the best choice for this type of angioedema. Epinephrine targets histamine-mediated reactions and is essential for anaphylaxis, but it doesn’t address the bradykinin pathway as effectively here. Cromolyn sodium and hydrocortisone have limited or inconsistent benefit for bradykinin-mediated ACE inhibitor–induced edema. In practice, discontinue the ACE inhibitor and provide airway monitoring and supportive care, with icatibant as the preferred agent to counter the bradykinin-driven swelling.

ACE inhibitor–induced angioedema is driven by excess bradykinin because these drugs prevent its breakdown, leading to edema that is not primarily driven by histamine. Treatments that block histamine or rely on allergic pathways often don’t work well in this scenario. Icatibant is a selective bradykinin B2 receptor antagonist, so it directly blocks the effects of bradykinin on blood vessels, reducing vasodilation and vascular permeability and shortening the swelling. That direct mechanism makes it the best choice for this type of angioedema. Epinephrine targets histamine-mediated reactions and is essential for anaphylaxis, but it doesn’t address the bradykinin pathway as effectively here. Cromolyn sodium and hydrocortisone have limited or inconsistent benefit for bradykinin-mediated ACE inhibitor–induced edema. In practice, discontinue the ACE inhibitor and provide airway monitoring and supportive care, with icatibant as the preferred agent to counter the bradykinin-driven swelling.